US Patent Issued to Temple University-Of The Commonwealth System of Higher Education on Nov. 11 for "(S)-2-amino-6-((3-aminopropyl)amino)hexanoic acid (APL) for use in the treatment of non-alcoholic steatohepatitis (NASH), liver inflammation, hepatocellular ballooning, liver fibrosis and steatosis" (Pennsylvania Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,582, issued on Nov. 11, was assigned to Temple University-Of The Commonwealth System of Higher Education (Philadelphia).

"(S)-2-amino-6-((3-aminopropyl)amino)hexanoic acid (APL) for use in the treatment of non-alcoholic steatohepatitis (NASH), liver inflammation, hepatocellular ballooning, liver fibrosis and steatosis" was invented by Salim Merali (Philadelphia), Wayne E. Childers (Philadelphia), Carlos Barrero (Philadelphia), George C. Morton (Philadelphia) and Mario Cesar Rico (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "(S)-2-amino-6-((3-aminopropyl)amino)hexanoic acid (APL) for use in the treatment of non-alcoholic steatohepatiti...